ALRS
Alerus Financial Corporation
ALRS's outlook is improving despite an expensive valuation.
BAC
Bank of America Corporation
BAC has the edge over ALRS overall, supported by stronger fundamentals and stronger valuation.
ALRS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| N/A | |
| N/A |
ALRS's revenue and profitability are currently stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ALRS.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ALRS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.5x | $11.26 | -67% |
| Fair | 12x | $13.75 | -60% |
| Forward | 12x | $34.27 | — |
| Current | 29x | $34.27 | — |
| Expensive | 35x | $41.75 | +22% |
Historical ranges are pointers, not guarantees.
ALRS's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over ALRS in the historical PE scenario, which offers more potential upside but is not a forecast.
ALRS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ALRS, with profitability improving.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
ALRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.86 | +140% |
| Q3 2026 | $1.19 | -37% |
| Q2 2026 | $1.08 | -28% |
| Q1 2026 | $1.05 | +1.9% |
| Q4 2025 | $0.68 | -18% |
| Q3 2025 | $1.89 | +1012% |
| Q2 2025 | $1.50 | +317% |
| Q1 2025 | $1.03 | +106% |
| Q4 2024 | $0.83 | +43% |
ALRS's earnings per share have fallen from their peak: $1.19 over the past year, against $3.14 in mid-2021.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
ALRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $81.1M | +12% |
| Q2 2026 | $80.7M | +7.8% |
| Q1 2026 | $75.8M | +10% |
| Q4 2025 | $8.2M | -89% |
| Q3 2025 | $72.6M | +43% |
| Q2 2025 | $74.8M | +46% |
| Q1 2025 | $68.8M | +45% |
| Q4 2024 | $72.2M | +223% |
ALRS's revenue is down over the past year, though its latest quarter was up: $81M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +0.5 points |
| Q2 2026 | 34% | -1.4 points |
| Q1 2026 | 40% | +14 points |
| Q4 2025 | -527% | -527 points |
| Q3 2025 | 30% | +17 points |
| Q2 2025 | 35% | +19 points |
| Q1 2025 | 26% | +7.6 points |
| Q4 2024 | -0.4% | +79 points |
ALRS has the edge over BAC on profitability, with a higher operating margin.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ALRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $52.7M | +74% |
| Q2 2026 | $17.9M | +137% |
| Q1 2026 | $25.8M | +356% |
| Q4 2025 | $15.3M | +241% |
| Q3 2025 | $30.3M | +87% |
| Q2 2025 | $7.6M | +$22.7M |
| Q1 2025 | $5.7M | -49% |
| Q4 2024 | $4.5M | +$7.5M |
ALRS has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ALRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -234K shares |
| 1 year | -2.1% | -552K shares |
| 3 years | +25% | +5.1M shares |
| 5 years | +44% | +7.7M shares |
| Available history | +67% | +10.1M shares |
ALRS has 25M diluted shares, down 2.1% from a year ago, with $22M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8.3M |
| Q2 2026 | $7.1M |
| Q1 2026 | $6.5M |
| Q4 2025 | $219,000 |
| Q3 2025 | $342,000 |
| Q2 2025 | $49,000 |
| Q1 2025 | $127,000 |
| Q4 2024 | $44,000 |
ALRS spent $22M buying back its own shares over the past year, more than ten times what it spent the year before.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ALRS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ALRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.9x | High |
| Q2 2026 | 5.8x | High |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 7.9x | High |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 4.6x | High |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 7.2x | High |
ALRS has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ALRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.7 | Neutral |
| Stochastic | 74.9 | Neutral |
ALRS's weekly RSI is 68 (neutral) and its Stochastic is 75 (neutral).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ALRS PE vs Financial Services Sector
| Metric | ALRS | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 13x | 121% above |
| PE % | 76 | 63 | 13 pts above |
ALRS is trading at 29x earnings, a 121% premium to the Financial Services sector's median of 13x.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over ALRS on valuation relative to its sector.
ALRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $32.6 | 5.2% above |
| 20 week MA | $32.7 | 4.8% above |
| 50 week MA | $28.3 | 21% above |
| 100 week MA | $24.5 | 40% above |
| 200 week MA | $22.2 | 55% above |
ALRS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ALRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.8 | $27.1 | +19% |
| 2021 | $27.1 | $29.5 | +8.9% |
| 2022 | $29.5 | $23.3 | -21% |
| 2023 | $23.3 | $22.4 | -3.9% |
| 2024 | $22.4 | $19.2 | -14% |
| 2025 | $19.2 | $21.8 | +13% |
| 2026 YTD | $21.8 | $34.3 | +57% |
ALRS has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.